European Drug Development Consulting SRL
European Drug Development Consulting reported total assets of 163,032 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
By total assets for 2025, European Drug Development Consulting ranks in the top half of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of European Drug Development Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +47 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
European Drug Development Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 223,735 € | ||||
| Equity | 30,078 € | ||||
| Cash | 68,799 € | ||||
| EBITDA | 311,219 € | ||||
| Total assets | 163,032 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
European Drug Development Consulting's financial analysis
- Solvency18.4%sector median: 52.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of European Drug Development Consulting
1 active director(s) in the register.
European Drug Development Consulting's shareholders and holdings →European Drug Development Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0540.806.771
- VAT number
- BE0540806771
- Peppol
- Registered · 0208:0540806771 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Oct 2013
- Registered office
- 4540 Amay
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Public relations and communication activities (NACE 73300)
European Drug Development Consulting (SRL) has been based in Amay since 2013, active in: public relations and communication activities. For 2025, it reports a net profit of 223,735 € and equity of 30,078 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to European Drug Development Consulting
Companies in the same business, of comparable size and area, outside its group.
- European Resource Development Public relations and communication activities Overijse · balance sheet 162,899 €
- LJE Consulting Public relations and communication activities Bilzen-Hoeselt · balance sheet 163,476 €
- Wils Consulting Public relations and communication activities Beerse · balance sheet 163,582 €
- HunkeR Public relations and communication activities Wielsbeke · balance sheet 163,601 €
- Mosy Consulting Public relations and communication activities Zemst · balance sheet 162,343 €
- Breezeconsult Public relations and communication activities Lokeren · balance sheet 164,054 €
- Pendo Public relations and communication activities Etterbeek · balance sheet 161,614 €
- Bdheer Public relations and communication activities Overijse · balance sheet 164,960 €
Frequently asked questions about European Drug Development Consulting
What is the revenue of European Drug Development Consulting?
European Drug Development Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of European Drug Development Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0540806771 for European Drug Development Consulting, if the company is VAT-registered. Its company number (CBE) is 0540.806.771.
Where is the registered office of European Drug Development Consulting?
According to the CBE register, the registered office of European Drug Development Consulting is in 4540 Amay.
What is the equity of European Drug Development Consulting?
At the close of the 2025 financial year, the equity of European Drug Development Consulting amounts to 30,078 €, a solvency of 18.4% of total assets.
Who manages European Drug Development Consulting?
The register lists 1 active mandates at European Drug Development Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is European Drug Development Consulting within its sector?
By total assets for 2025, European Drug Development Consulting ranks in the top half of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year.
The full file of European Drug Development Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →